2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow IBI302: new trials by email Literature Review of IBI302 trials Research Report on IBI302
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Evaluate the Safety and Tolerability of Repeated Intravitreal Injection of IBI302 in Neovascular AMD Patients IBI302 (the first dose level), IBI302 (the second dose level), Aflibercept - Neovascular Age-related Macular Degeneration | Phase 1 | Completed | Innovent Biologics (Suzhou) Co. Ltd. | 18 | 2020-05-28 | 2021-11-11 |
| A Dose Escalation Study of IBI302 in Patients With Wet Age-related Macular Degeneration IBI302 - Neovascular Age-related Macular Degeneration | Phase 1 | Completed | Innovent Biologics (Suzhou) Co. Ltd. | 31 | 2019-04-15 | 2025-04-17 |
Innovent Biologics (Suzhou) Co. Ltd. (2)
China (2)